277 related articles for article (PubMed ID: 12915642)
1. Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes.
Garber AJ; Donovan DS; Dandona P; Bruce S; Park JS
J Clin Endocrinol Metab; 2003 Aug; 88(8):3598-604. PubMed ID: 12915642
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes.
Garber AJ; Larsen J; Schneider SH; Piper BA; Henry D;
Diabetes Obes Metab; 2002 May; 4(3):201-8. PubMed ID: 12047399
[TBL] [Abstract][Full Text] [Related]
3. Durability of efficacy and long-term safety profile of glyburide/metformin tablets in patients with type 2 diabetes mellitus: an open-label extension study.
Garber AJ; Bruce S; Fiedorek FT
Clin Ther; 2002 Sep; 24(9):1401-13. PubMed ID: 12380632
[TBL] [Abstract][Full Text] [Related]
4. Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study.
Lewin A; Lipetz R; Wu J; Schwartz S
Clin Ther; 2007 May; 29(5):844-855. PubMed ID: 17697903
[TBL] [Abstract][Full Text] [Related]
5. A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patients.
Erle G; Lovise S; Stocchiero C; Lora L; Coppini A; Marchetti P; Merante D
Acta Diabetol; 1999 Jun; 36(1-2):61-5. PubMed ID: 10436254
[TBL] [Abstract][Full Text] [Related]
6. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.
DeFronzo RA; Goodman AM
N Engl J Med; 1995 Aug; 333(9):541-9. PubMed ID: 7623902
[TBL] [Abstract][Full Text] [Related]
8. Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.
Dailey GE; Mohideen P; Fiedorek FT
Clin Ther; 2002 Sep; 24(9):1426-38. PubMed ID: 12380634
[TBL] [Abstract][Full Text] [Related]
9. Effect of glyburide-metformin combination tablet in patients with type 2 diabetes.
Chien HH; Chang CT; Chu NF; Hsieh SH; Huang YY; Lee IT; Lee WJ; Tang YJ; Sheu WH
J Chin Med Assoc; 2007 Nov; 70(11):473-80. PubMed ID: 18063500
[TBL] [Abstract][Full Text] [Related]
10. Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes.
Dailey GE
Expert Opin Pharmacother; 2003 Aug; 4(8):1417-30. PubMed ID: 12877648
[TBL] [Abstract][Full Text] [Related]
11. Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin.
Blonde L; Wogen J; Kreilick C; Seymour AA
Diabetes Obes Metab; 2003 Nov; 5(6):424-31. PubMed ID: 14617228
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of preprandial or postprandial Humalog Mix75/25 versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus.
Herz M; Sun B; Milicevic Z; Erickson P; Fövènyi J; Grzywa M; Pelikanova T
Clin Ther; 2002 Jan; 24(1):73-86. PubMed ID: 11833837
[TBL] [Abstract][Full Text] [Related]
13. Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial.
Dailey GE; Noor MA; Park JS; Bruce S; Fiedorek FT
Am J Med; 2004 Feb; 116(4):223-9. PubMed ID: 14969649
[TBL] [Abstract][Full Text] [Related]
14. Improvements in glycemic control in type 2 diabetes patients switched from sulfonylurea coadministered with metformin to glyburide-metformin tablets.
Duckworth W; Marcelli M; Padden M; Kellick K; Duhancik T; Wilhardt M; Colgan K; Romie A
J Manag Care Pharm; 2003; 9(3):256-62. PubMed ID: 14613469
[TBL] [Abstract][Full Text] [Related]
15. Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin.
Marre M; Howlett H; Lehert P; Allavoine T
Diabet Med; 2002 Aug; 19(8):673-80. PubMed ID: 12147149
[TBL] [Abstract][Full Text] [Related]
16. Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
Rosenstock J; Rood J; Cobitz A; Biswas N; Chou H; Garber A
Diabetes Obes Metab; 2006 Nov; 8(6):650-60. PubMed ID: 17026489
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of glyburide/metformin tablets (Glucovance) versus equivalent doses of glyburide and metformin in patients with type 2 diabetes.
Donahue SR; Turner KC; Patel S
Clin Pharmacokinet; 2002; 41(15):1301-9. PubMed ID: 12452739
[TBL] [Abstract][Full Text] [Related]
18. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
Kahn SE; Haffner SM; Heise MA; Herman WH; Holman RR; Jones NP; Kravitz BG; Lachin JM; O'Neill MC; Zinman B; Viberti G;
N Engl J Med; 2006 Dec; 355(23):2427-43. PubMed ID: 17145742
[TBL] [Abstract][Full Text] [Related]
19. Tolerability profile of metformin/glibenclamide combination tablets (Glucovance): a new treatment for the management of type 2 diabetes mellitus.
Davidson JA; Scheen AJ; Howlett HC
Drug Saf; 2004; 27(15):1205-16. PubMed ID: 15588116
[TBL] [Abstract][Full Text] [Related]
20. Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy.
Garber A; Klein E; Bruce S; Sankoh S; Mohideen P
Diabetes Obes Metab; 2006 Mar; 8(2):156-63. PubMed ID: 16448519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
